2015-2019 Spain Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

September 2015 | 565 pages | ID: 2EFEFB04BC8EN
Venture Planning Group

Abstracts

Complete report $6,800. DataPack (test volumes, sales forecasts, supplier shares) $3,450. 2015-2019 Spain Cancer Diagnostics Market is a newstrategic analysis of the major business opportunities emerging in the cancer diagnostics market during the nextfive years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion. Business Opportunities and Strategic Recommendations- Specific new product development opportunities with potentiallysignificant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies.

Potential market entry barriers and risks. Cancer Diagnostic Tests—Over 200 current and emerging assays including:ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27. 29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others. Market Segmentation Analysis- Sales and market shares of major suppliers, by individual cancer diagnostic test. - Five-year test volume and sales forecasts for major cancer diagnostic tests by market segment, including:- Hospitals- Commercial/Private Laboratories- Comprehensive market segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliers. - Cancer statistics, etiology and recent developments. Current and Emerging Products- Review of over 200 current and emerging cancer diagnostic tests,including:- Biochemical Markers- Oncogenes- Growth Factors- Hormones- Colony Stimulating Factors- Lymphokines- Immunohistochemical Stains, and others. - Analysis of major immunoassay analyzers used forcancer diagnostic testing, including their operating characteristics,features and selling prices. Technology Review- Assessment of monoclonal antibodies, immunoassays, DNAprobes, biochips/microarrays, chromosome analysis, IT,artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing. - Review of competing/complementing technologies, includingCT, MRI, NMR, PET and photonics spectroscopy. - Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments- Strategic assessments ofmajor suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborativearrangements, and new products in R&D. Contains 565 pages and 85 tables

Contents

INTRODUCTION

EXECUTIVE SUMMARY

RATIONALE FOR TESTING DECENTRALIZATION
  1. OVERVIEW
  2. REGULATORY TRENDS
  3. ECONOMIC TRENDS
  4. DEMOGRAPHIC TRENDS
  5. TECHNOLOGICAL TRENDS
  6. SOCIAL TRENDS
  7. QUALITY OF CARE
  8. DEFENSIVE MEDICINE
  9. QUALITY CONTROL ISSUES
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine Chemistry Tests
  1. ALBUMIN
  2. ALKALINE PHOSPHATASE
  3. ALT/SGPT
  4. AMMONIA
  5. AMYLASE
  6. AST/SGOT
  7. BILIRUBIN
  8. BLOOD GASES
  9. BLOOD UREA NITROGEN (BUN)
  10. CALCIUM
  11. CHOLESTEROL
  12. CHOLINESTERASE
  13. CREATININE
  14. ELECTROLYTES
    a. Carbon Dioxide/Bicarbonate
    b. Chloride
    c. Potassium
    d. Sodium
  15. FERRITIN
  16. FOLLATE/FOLIC ACID
  17. FRUCTOSAMINE
  18. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
  19. GLUCOSE
  20. HIGH DENSITY LIPOPROTEIN (HDL)
  21. IRON
  22. LACTATE DEHYDROGENASE (LDH)
  23. MAGNESIUM
  24. PHOSPHORUS
  25. PROTEIN
  26. TRIGLYCERIDES
  27. TROPONIN
  28. URIC ACID
  29. URINALYSIS
  30. VITAMIN B12

INFECTIOUS DISEASE TESTS

  1. AIDS
  2. ADENOVIRUS
  3. CAMPYLOBACTER
  4. CANDIDA
  5. CHLAMYDIA
  6. CLOSTRIDIUM DIFFICILE
  7. CYTOMEGALOVIRUS
  8. ENTEROVIRUSES
  9. EPSTEIN-BARR VIRUS
  10. GONORRHEA
  11. HELICOBACTER PYLORI
  12. HEPATITIS
    a. Hepatitis A
    b. Hepatitis B
    c. Hepatitis C
    d. Hepatitis D
  13. HERPES SIMPLEX VIRUS
  14. HUMAN HERPES VIRUS-6 (HHV-6)
  15. INFLUENZA VIRUSES
  16. LEGIONELLA
  17. LYME DISEASE
  18. MEASLES (RUBEOLA)
  19. MENINGITIS
  20. MONONUCLEOSIS
  21. MUMPS
  22. MYCOPLASMA
  23. PAPILLOMAVIRUSES
  24. PNEUMONIA
  25. RESPIRATORY SYNCYTIAL VIRUS (RSV)
  26. RHEUMATOID ARTHRITIS
  27. ROTAVIRUS (REOVIRUS)
  28. RUBELLA (GERMAN MEASLES)
  29. SALMONELLOSIS
  30. SHIGELLOSIS
  31. STAPHYLOCOCCUS AUREUS
  32. STREPTOCOCCI
  33. SYPHILIS

TUMOR MARKERS

  1. ALPHA-FETOPROTEIN (AFP)
  2. CARCINOEMBRIONIC ANTIGEN (CEA)
  3. OCCULT BLOOD
  4. PROSTATIC ACID PHOSPHATASE (PAP)
  5. PROSTATE-SPECIFIC ANTIGEN (PSA)
MAJOR ROUTINE AND SPECIAL HEMATOLOGY TESTS
  1. CBC ANALYSIS
    a. Hemoglobin Concentration
    b. Hematocrit Determination
    c. Red Blood Cell Count
    d. Platelets

ENDOCRINE FUNCTION TESTS

  1. CORTISOL
  2. FOLLICLE-STIMULATING HORMONE (FSH)
  3. GASTRIN
  4. HUMAN CHORIONIC GONADOTROPIN (HCG)
  5. LH
  6. PROLACTIN
  7. T3
  8. T3 UPTAKE
  9. FREE T3
  10. THYROXINE (T4)
  11. FREE T4
  12. TBG
  13. TSH
Therapeutic Drug Monitoring (TDM)
  1. OVERVIEW
  2. CARBAMAZEPINE
  3. DIGOXIN
  4. GENTAMICIN
  5. LIDOCAINE
  6. LITHIUM
  7. PHENYTOIN/DILANTIN
  8. PROCAINAMIDE
  9. QUINIDINE
  10. THEOPHYLLINE
  11. VALPROIC ACID
Coagulation Tests
  1. INTRODUCTION
  2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
  3. ALPHA-2 ANTIPLASMIN
  4. ANTITHROMBIN III
  5. BLEEDING TIME
  6. D-DIMER
  7. FACTOR VIII
  8. FIBRIN DEGRADATION PRODUCTS
  9. FIBRINOGEN
  10. HEPARIN
  11. PROTEINS C AND S
  12. PROTHROMBIN TIME (PT)
  13. THROMBIN TIME
Immunoprotein Tests
  1. CRP
  2. IMMUNOGLOBULINS
Drugs of Abuse
  1. OVERVIEW
  2. TEST METHODOLOGIES
  3. AMPHETAMINES
  4. BARBITURATES
  5. BENZODIAZEPINES
  6. CANNABINOIDS/MARIJUANA
  7. COCAINE
  8. LYSERGIC ACID DIETHYLAMIDE (LSD)
  9. METHADONE
  10. METHAQUALONE
  11. OPIATES
  12. PHENCYCLIDINE

INSTRUMENTATION

  1. CHEMISTRY ANALYZERS MANUFACTURED BY:
  Abaxis
  Abbott
  Alfa Wassermann
  Awareness Technologies
  Beckman Coulter/Danaher
  bioMeriuex
  Carolina Chemistries
  Horiba
  Inverness
  Medica
  Nova Biomedical
  Ortho-Clinical Diagnostics
  Polimedco
  Randox
  Roche
  2. HEMATOLOGY ANALYZERS MANUFACTURED BY:
  Abbott
  Becton Dickinson
  Beckman Coulter/Danaher
  Biocode
  Drew-Scientific
  Diesse Ves Matic
  Horiba
  Menarini
  Nihon Kohden
  Polymedco
  Sysmex
  3. COAGULATION ANALYZERS MANUFACTURED BY:
  Behnk Elektronik
  Bio/Data
  Cardiovascular Diagnostics
  Diagnostica Stago
  Helena Laboratories
  INSTRUMENTATION Laboratory
  ITC Hemochron
  Roche
  Siemens
  Sysmex
  Teco Medical Instruments
  Trinity Biotech
CURRENT AND EMERGING TECHNOLOGIES
  1. MONOCLONAL ANTIBODIES
  2. IMMUNOASSAYS
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      Dot Immunobinding Assays
      Capillary Immunoassays
      Particle-Membrane Capture Immunoassay
      Enzyme Amplification
    c. Fluorescent Immunoassays
      Fluorescent Polarization
      Time-Resolved Pulse Fluorescence
    d. Luminescence
      Chemiluminescence
      Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  3. DRY CHEMISTRY
  4. BIOSENSORS
  5. IT AND AUTOMATION
  6. MOLECULAR DIAGNOSTICS
    a. Technology Overview
    b. Amplification Methods
      Polymerase Chain Reaction
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      Strand Displacement Activation
      Self-Sustained Sequence Replicase

WORLDWIDE BUSINESS ENVIRONMENT


U.S.A.

A. Market Overview
  1. BUSINESS ENVIRONMENT
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
      PPO
      HMO
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
      More Chronic Illness
      Disease Incidence
      Susceptibility to latrogenesis
      Multiple Illnesses Cases
    l. Laboratory Regulations
  2. MARKET STRUCTURE
    a. Hospitals
    b. Commercial/Private Laboratories
B. Personal Testing
  1. GLUCOSE MONITORING
      Market and Technology Overview
      Invasive Testing
      Non-Invasive Testing
      Genetic Testing
  2. PREGNANCY TESTS
  3. OCCULT BLOOD TESTS
  4. MARKET SIZE AND GROWTH
C. Physician Offices/Group Practices
  1. MARKET SUMMARY
  2. MARKET STRUCTURE
  3. TEST VOLUME AND SALES FORECASTS
D. Ancillary Hospital Locations
  1. INTRODUCTION
    a. Emergency Departments
    b. Operating Suites
    c. Intensive Care Units
  2. EMERGENCY DEPARTMENTS
    a. Market Summary
    b. Test volume and Sales Forecasts
  3. OPERATING AND RECOVERY SUITES
    a. Market Summary
    b. Test Volume and Sales Forecasts
  4. ICUS/CCUS A. MARKET SUMMARY
    b. Test Volume and Sales Forecasts
E. Cancer Clinics
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. TEST VOLUME AND SALES FORECASTS
F. Ambulatory Care Centers
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
G. Surgery Centers
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
H. Nursing Homes
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS

1. BIRTH CENTERS

  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
J. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPANY PROFILE

  Abbott
  ADI/American Diagnostica
  Agilent Technologies
  Alere/Biosite/Inverness
  Axis-Shield
  Beckman Coulter/Danaher
  Becton Dickinson
  Bio/Data
  Biomerieux
  Bio-Rad
  Cepheid
  Chrono-Log
  Corgenix
  Decode Genetics
  Diadexus
  Diagnocure
  Diagnostica Stago/Trinity Biotech
  Diamedix
  Diasorin
  Eiken Chemical
  EKF Diagnostics
  Fujirebio
  Grifols
  Helena Laboratories
  Hologic/Gen-Probe
  Horiba
  INSTRUMENTATION Laboratory
  International Technidyne/Nexus DX
  Kreatech/Leica
  Kyowa Medex
  Lonza
  Mackay Life Sciences
  Matritech
  Nihon Kohden
  Ortho-Clinical Diagnostics
  Polartechnics
  Polymedco
  Qiagen
  Roche
  SDIX
  Sequenom
  Siemens
  Sienco
  Sysmex
  Takara Bio
  ThermoFisher
  Tosoh
  Wako
  Zycare/Alere

List Of Tables

LIST OF TABLES

EXECUTIVE SUMMARY Table I: All Decentralized Testing Markets, Diagnostics Sales Forecasts by Market Segment
EXECUTIVE SUMMARY Table II: All Decentralized Testing Markets, Reagent Sales Forecasts by Market Segment
EXECUTIVE SUMMARY Table III: All Decentralized Testing Markets, Instrument Sales Forecasts by Market Segment
Major Companies Developing or Marketing Albumin Tests
Major Companies Developing or Marketing Alkaline Phosphatase Tests
Major Companies Developing or Marketing ALT/SGPT Tests
Major Companies Developing or Marketing Amylase Tests
Major Companies Developing or Marketing AST/SGOT Tests
Major Companies Developing or Marketing Bilirubin Tests
Major Companies Developing or Marketing Blood Gas Analyzers
Major Companies Developing or Marketing BUN Tests
Major Companies Developing or Marketing Calcium Tests
Major Companies Developing or Marketing Cholesterol Tests
Major Companies Developing or Marketing Creatinine Tests
Major Companies Developing or Marketing Electrolyte Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing GGT Tests
Major Companies Developing or Marketing Glucose Tests
Major Companies Developing or Marketing HDL Tests
Major Companies Developing or Marketing Iron Tests
Major Companies Developing or Marketing LDH Tests
Major Companies Developing or Marketing Magnesium Tests
Major Companies Developing or Marketing Phosphorus Tests
Major Companies Developing or Marketing Protein Tests
Major Companies Developing or Marketing Triglycerides Tests
Major Companies Developing or Marketing Uric Acid Tests
Major Companies Developing or Marketing Vitamin B-12/Folate Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing FSH Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing LH Tests
Major Companies Developing or Marketing Prolactin Tests
Major Companies Developing or Marketing T3 Tests
Major Companies Developing or Marketing T4 Tests
Major Companies Developing or Marketing TSH Tests
Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin/Dilantin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing Valproic Acid Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-Dimer Tests
Major Companies Developing or Marketing Factor Assays Tests
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing CRP Tests
Major Companies Developing or Marketing Drugs of Abuse Tests
U.S.A., Personal Testing Total Diagnostic Market Forecast
U.S.A., Physician Offices/Group Practices Total Diagnostic Sales Forecast by Market Segment
U.S.A., Physician Offices/Group Practices Reagent Sales Forecast by Market Segment
U.S.A., Physician Offices/Group Practices Instrument Sales Forecast by Market Segment
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
U.S.A., Physician Offices Laboratories Major Infectious Disease Test Volume Forecast
U.S.A., Physician Offices/Group Practice Microbiology Test Volume Forecast by Market Segment
U.S.A., Physician Offices/Group Practices Routine Hematology Test Volume Forecast
U.S.A., Physician Offices Laboratories Flow Cytometry and Special Hematology Test Volume Forecast
U.S.A., Physician Offices/Group Practices Coagulation Test Volume Forecast
U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast
U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast
U.S.A., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
U.S.A., Physician Offices/Group Practices Immunoprotien Test Volume Forecast
U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Microbiology/Infectious Disease Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Tumor Markers Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Immunoprotein Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Physician Offices Laboratories Major Infectious Disease Reagent Market Forecast by Test
U.S.A., Physician Offices/Group Practices Microbiology Reagent Market Forecast by Market Segment
U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Consumables Market Forecast
U.S.A., Physician Offices/Group Practices TDM Reagent Market Forecast by Test
U.S.A., Physician Offices/Group Practices Endocrine Function Reagent Market Forecast by Test
U.S.A., Physician Offices/Group Practices Major Tumor Marker Reagent Market Forecast by Test
U.S.A., Physician Offices/Group Practices Coagulation Reagent Market Forecast
U.S.A., Physician Offices/Group Practices Immunoprotein Reagent Market Forecast by Test
U.S.A., Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast by Test
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Total Diagnostics Sales Forecast by Market Segment
U.S.A., Hospital Emergency Departments Reagent Sales Forecast by Market Segment
U.S.A., Hospital Emergency Departments Instrument Sales Forecast by Market Segment
U.S.A., Hospital Emergency Departments Routine and Special Chemistry Test Volume Forecast
U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
U.S.A., Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
U.S.A., Hospital Emergency Departments Routine Hematology Test Volume Forecast
U.S.A., Hospital Emergency Departments Coagulation Test Volume Forecast
U.S.A., Hospital Emergency Departments Selected Infectious Disease Test Volume Forecast
U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital Emergency Departments Drugs of Abuse Reagent Market Forecast by Test
U.S.A., Hospital Emergency Departments Hematology Reagent Market Forecast
U.S.A., Hospital Emergency Departments Coagulation Reagent Market Forecast
U.S.A., Hospital Emergency Departments Selected Infectious Disease Reagent Market Forecast by Test
U.S.A., Hospital Operating and Recovery Suites Total Diagnostics Sales Forecast by Market Segment
U.S.A., Hospital Operating and Recovery Suites Reagent Sales Forecast by Market Segment
U.S.A., Hospital Operating and Recovery Suites Instrument Sales Forecast By Market Segment
U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Routine Hematology Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Coagulation Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital Operating and Recovery Suites Hematology Reagent Market Forecast
U.S.A., Hospital Operating and Recovery Suites Coagulation Reagent Market Forecast
U.S.A., Hospital ICUs/CCUs Total Diagnostics Sales Forecast by Market Segment
U.S.A., Hospital ICUs/CCUs Reagent Sales Forecast by Market Segment
U.S.A., Hospital ICUs/CCUs Instrument Sales Forecast by Market Segment
U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Routine Hematology Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Coagulation Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital ICUs/CCUs Hematology Reagent Market Forecast
U.S.A., Hospital ICUs/CCUs Coagulation Reagent Market Forecast
U.S.A., Cancer Clinics Total Diagnostics Sales Forecast by Market Segment
U.S.A., Cancer Clinics Reagent Sales Forecast by Market Segment
U.S.A., Cancer Clinics Instrument Sales Forecast by Market Segment
U.S.A., Cancer Clinics Major Tumor Markers Test Volume Forecast
U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
U.S.A., Cancer Clinics Routine Hematology/Flow Cytometry Test Volume Forecast
U.S.A., Cancer Clinics Endocrine Function Test Volume Forecast
U.S.A., Cancer Clinics Coagulation Test Volume Forecast
U.S.A., Cancer Clinics Major Tumor Marker Sales Forecast by Test
U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Cancer Clinics Hematology And Flow Cytometry Reagent Market Forecast
U.S.A., Cancer Clinics Endocrine Function Reagent Market Forecast
U.S.A., Cancer Clinics Coagulation Reagent Market Forecast
U.S.A., Ambulatory Care Centers Total Diagnostics Sales Forecast by Market Segment
U.S.A., Ambulatory Care Centers Reagent Sales Forecast by Market Segment
U.S.A., Ambulatory Care Centers Instrument Sales Forecast by Market Segment
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine and Special Chemistry Test Volume Forecast
U.S.A., Ambulatory Care Centers Routine Hematology Test Volume Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Test Volume Forecast
U.S.A., Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
U.S.A., Ambulatory Care Centers Coagulation Test Volume Forecast
U.S.A., Ambulatory Care Centers Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Drugs of Abuse Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Hematology Reagent Market Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Coagulation Reagent Market Forecast
U.S.A., Surgery Centers Total Diagnostics Sales Forecast by Market Segment
U.S.A., Surgery Centers Reagent Sales Forecast by Market Segment
U.S.A., Surgery Centers Instrument Sales Forecast by Market Segment
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Routine and Special Chemistry Test Volume Forecast
U.S.A., Surgery Centers Routine Hematology Test Volume Forecast
U.S.A., Surgery Centers Coagulation Test Volume Forecast
U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
U.S.A., Surgery Centers Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Surgery Centers Hematology Consumable Market Forecast
U.S.A., Surgery Centers Coagulation Reagent Market Forecast
U.S.A., Nursing Homes Total Diagnostics Sales Forecast by Market Segment
U.S.A., Nursing Homes Reagent Sales Forecast by Market Segment
U.S.A., Nursing Homes Instrument Sales Forecast by Market Segment
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes Routine and Special Chemistry Test Volume Forecast
U.S.A., Nursing Homes Coagulation Test Volume Forecast
U.S.A., Nursing Homes Routine Hematology Test Volume Forecast
U.S.A., Nursing Homes Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Nursing Homes Coagulation Reagent Market Forecast
U.S.A., Nursing Homes Hematology Reagent Market Forecast
U.S.A., Birth Centers Total Diagnostics Sales Forecast by Market Segment
U.S.A., Birth Centers Reagent Sales Forecast by Market Segment
U.S.A., Birth Centers Instrument Sales Forecast by Market Segment
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Routine and Special Chemistry Test Volume Forecast
U.S.A., Birth Centers Profiles, Panels and Individual Tests
U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
U.S.A., Birth Centers Coagulation Test Volume Forecast
U.S.A., Birth Centers Routine Hematology Test Volume Forecast
U.S.A., Birth Centers Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Birth Centers Microbiology and Serology Testing Market Forecast
U.S.A., Birth Centers Hematology Reagent Market Forecast
U.S.A., Birth Centers Coagulation Reagent Market Forecast
U.S.A., Major Suppliers of Clinical Chemistry Diagnostics Products, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Immunoassay Reagent Estimated Sales and Market Shares
U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Sales and Market Shares
U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., AFP Testing Market By Major Suppliers
U.S.A., CA 15-3/27-29 Testing Market by Major Suppliers
U.S.A., CA 19-9 Testing Market by Major Suppliers
U.S.A., CEA Testing Market by Major Suppliers
U.S.A., PAP Testing Market by Major Suppliers
U.S.A., PSA Testing Market by Major Suppliers
U.S.A., Hematology Analyzers Estimated Placements and Installed Base
U.S.A., Flow Cytometers Estimated Placements and Installed Base
U.S.A., Hematology Diagnostics Market Estimated Market Shares of Major Suppliers
U.S.A., Hematology Instrument Market Estimated Market Shares of Major Suppliers
U.S.A., Hematology Consumable Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Diagnostics Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Consumable Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Instruments Market Estimated Market Shares of Major Suppliers
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Market Shares of Major Suppliers